Lightbridge FY2025 net loss widens to $19.6M; working capital jumps to $201.7M

LIGHTBRIDGE Corp

Net loss of $19.6M vs $11.8M in FY2024; R&D expenses doubled to $9.2M on fuel development activities.
Working capital rose to $201.7M from $39.9M; cash and equivalents reached $201.9M, driven by $176M net ATM equity sales.
Co-extruded depleted and enriched uranium-zirconium alloy samples with Idaho National Lab; testing started at Advanced Test Reactor.
General and administrative expenses increased $5.5M to $14.0M, primarily due to stock-based compensation and professional fees.
No revenue reported; company remains a pre-commercial advanced nuclear fuel technology developer.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.